Author:
Gupta Sapna,Priya Nivedita
Publisher
Jaypee Brothers Medical Publishing
Reference28 articles.
1. 1. Subramanyam KS, Gosavi S, Tenneti D, et al. Evaluation of the role of hba1c in chronic kidney disease. J Clin Diagn Res 2018;12(7): BC01–BC04. DOI: 10.7860/JCDR/2018/34732.11732.
2. 2. National Kidney Foundation. How to classify CKD [internet]. 2015. Available from: https://www.kidney.org/professionals/explore-yourknowledge/how-to-classify-ckd.
3. 3. Britannica, The Editors of Encyclopedia. “Diabetes Mellitus”. Encyclopedia Britannica, 24 Oct. 2023.
4. 4. Ren J, Dai C. Pathophysiology of chronic kidney disease. In: Yang, J, He W. (eds). Chronic Kidney Disease. Singapore: Springer; 2020. DOI: 10.1007/978-981-32-9131-7_2.
5. 5. Wheeler DC, James J, Patel D, et al. SGLT2 inhibitors: Slowing of chronic kidney disease progression in type 2 diabetes. Diabetes Ther 2020;11(12):2757–2774. DOI: 10.1007/s13300-020-00930-x.